This guidance document focuses on the diagnosis and treatment of venous
thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining …

SIR produces its Standards of Practice documents by using the following process. Topics of
relevance and timeliness are conceptualized by the Standards of Practice Committee …

Purpose To provide evidence-based recommendations on the use of inferior vena cava
(IVC) filters in the treatment of patients with or at substantial risk of venous thromboembolic …

Inferior vena cava (IVC) filter placement is a relatively low risk alternative for prophylaxis
against pulmonary embolism in patients with pelvic or lower extremity deep venous …

Anticoagulation is the cornerstone for the treatment of deep venous thrombosis and
pulmonary embolism. On occasion, this is not possible because of bleeding complications …

Use of retrievable inferior vena cava filters (RIVCFs) has grown exponentially since their
introduction into clinical practice, but many of these devices are not retrieved. Some are not …

The care of patients with venous thromboembolism (VTE) is delivered via a multidisciplinary
team. The primary treatment for VTE is anticoagulation; however, placement of filter devices …

Nanomaterials research has significantly accelerated the development of the field of
vascular and interventional radiology. The incorporation of nanoparticles with unique and …

Venous thromboembolism (VTE), a disease that includes deep venous thrombosis (DVT)
and pulmonary embolism (PE), is associated with high mortality, morbidity, and costs. It can …

Importance Despite historically high rates of use, most inferior vena cava (IVC) filters are not
retrieved. The US Food and Drug Administration safety communications recommended …